BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 28418695)

  • 1. A Comparison of Different Staging Systems for Multiple Myeloma: Can the MRI Pattern Play a Prognostic Role?
    Filonzi G; Mancuso K; Zamagni E; Nanni C; Spinnato P; Cavo M; Fanti S; Salizzoni E; Bazzocchi A
    AJR Am J Roentgenol; 2017 Jul; 209(1):152-158. PubMed ID: 28418695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of
    Deng S; Zhang B; Zhou Y; Xu X; Li J; Sang S; Zhang W
    Contrast Media Mol Imaging; 2018; 2018():4198673. PubMed ID: 30154686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnetic resonance imaging as a supplement for the clinical staging system of Durie and Salmon?
    Baur A; Stäbler A; Nagel D; Lamerz R; Bartl R; Hiller E; Wendtner C; Bachner F; Reiser M
    Cancer; 2002 Sep; 95(6):1334-45. PubMed ID: 12216103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative study of fluorodeoxyglucose positron emission tomography and magnetic resonance imaging for the detection of spinal bone marrow infiltration in untreated patients with multiple myeloma.
    Hur J; Yoon CS; Ryu YH; Yun MJ; Suh JS
    Acta Radiol; 2008 May; 49(4):427-35. PubMed ID: 18415787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of MRI for the diagnosis and prognosis of multiple myeloma.
    Baur-Melnyk A; Buhmann S; Dürr HR; Reiser M
    Eur J Radiol; 2005 Jul; 55(1):56-63. PubMed ID: 15950101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FDG-PET in the evaluation of myeloma in 2012.
    Bodet-Milin C; Eugène T; Bailly C; Lacombe M; Frampas E; Dupas B; Moreau P; Kraeber-Bodéré F
    Diagn Interv Imaging; 2013 Feb; 94(2):184-9. PubMed ID: 23287424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Whole-body MRI versus whole-body MDCT for staging of multiple myeloma.
    Baur-Melnyk A; Buhmann S; Becker C; Schoenberg SO; Lang N; Bartl R; Reiser MF
    AJR Am J Roentgenol; 2008 Apr; 190(4):1097-104. PubMed ID: 18356461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation Between Baseline 18F-FDG PET/CT Findings and CD38- and CD138-Expressing Myeloma Cells in Bone Marrow and Clinical Parameters in Patients with Multiple Myeloma.
    Cengiz A; Arda HÜ; Döğer F; Yavaşoğlu İ; Yürekli Y; Bolaman AZ
    Turk J Haematol; 2018 Aug; 35(3):175-180. PubMed ID: 29806594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of anatomic and functional staging in myeloma: description of Durie/Salmon plus staging system.
    Durie BG
    Eur J Cancer; 2006 Jul; 42(11):1539-43. PubMed ID: 16777405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Staging monoclonal plasma cell disease: comparison of the Durie-Salmon and the Durie-Salmon PLUS staging systems.
    Fechtner K; Hillengass J; Delorme S; Heiss C; Neben K; Goldschmidt H; Kauczor HU; Weber MA
    Radiology; 2010 Oct; 257(1):195-204. PubMed ID: 20851941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Value of whole body MRI and dynamic contrast enhanced MRI in the diagnosis, follow-up and evaluation of disease activity and extent in multiple myeloma.
    Dutoit JC; Vanderkerken MA; Verstraete KL
    Eur J Radiol; 2013 Sep; 82(9):1444-52. PubMed ID: 23726124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imaging findings and clinical features of patients with multiple myeloma with the prognostic effect of bone marrow focal and diffuse infiltration patterns on spine MRI.
    Aribas BK; Arda K; Yologlu Z; Ciledag N; Aktas E; Ozdemir S; Dogan K; Fen T; Dagli M
    Minerva Med; 2011 Apr; 102(2):115-24. PubMed ID: 21483398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of magnetic resonance imaging of bone marrow in previously untreated patients with multiple myeloma.
    Moulopoulos LA; Gika D; Anagnostopoulos A; Delasalle K; Weber D; Alexanian R; Dimopoulos MA
    Ann Oncol; 2005 Nov; 16(11):1824-8. PubMed ID: 16087694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diffuse pattern of bone marrow involvement on magnetic resonance imaging is associated with high risk cytogenetics and poor outcome in newly diagnosed, symptomatic patients with multiple myeloma: a single center experience on 228 patients.
    Moulopoulos LA; Dimopoulos MA; Kastritis E; Christoulas D; Gkotzamanidou M; Roussou M; Koureas A; Migkou M; Gavriatopoulou M; Eleutherakis-Papaiakovou E; Gika D; Koutoulidis V; Terpos E
    Am J Hematol; 2012 Sep; 87(9):861-4. PubMed ID: 22641455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor load in patients with multiple myeloma: β2-microglobulin levels versus whole-body MRI.
    D'Anastasi M; Notohamiprodjo M; Schmidt GP; Dürr HR; Reiser MF; Baur-Melnyk A
    AJR Am J Roentgenol; 2014 Oct; 203(4):854-62. PubMed ID: 25247952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple myeloma.
    Baur-Melnyk A; Reiser MF
    Semin Musculoskelet Radiol; 2009 Jun; 13(2):111-9. PubMed ID: 19455474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contrast enhancement and quantitative signal analysis in MR imaging of multiple myeloma: assessment of focal and diffuse growth patterns in marrow correlated with biopsies and survival rates.
    Stäbler A; Baur A; Bartl R; Munker R; Lamerz R; Reiser MF
    AJR Am J Roentgenol; 1996 Oct; 167(4):1029-36. PubMed ID: 8819407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between magnetic resonance imaging patterns and baseline disease features in multiple myeloma: analyzing surrogates of tumour mass and biology.
    Mai EK; Hielscher T; Kloth JK; Merz M; Shah S; Hillengass M; Wagner B; Hose D; Raab MS; Jauch A; Delorme S; Goldschmidt H; Weber MA; Hillengass J
    Eur Radiol; 2016 Nov; 26(11):3939-3948. PubMed ID: 26767378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnetic resonance imaging pattern of bone marrow involvement as a new predictive parameter of disease progression in newly diagnosed patients with multiple myeloma eligible for autologous stem cell transplantation.
    Song MK; Chung JS; Lee JJ; Min CK; Ahn JS; Lee SM; Shin DY; Bae SH; Hong J; Lee GW; Lee IS; Shin HJ
    Br J Haematol; 2014 Jun; 165(6):777-85. PubMed ID: 24628463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extent of disease burden determined with magnetic resonance imaging of the bone marrow is predictive of survival outcome in patients with multiple myeloma.
    Ailawadhi S; Abdelhalim AN; Derby L; Mashtare TL; Miller KC; Wilding GE; Alberico RA; Gottlieb R; Klippenstein DL; Lee K; Chanan-Khan AA
    Cancer; 2010 Jan; 116(1):84-92. PubMed ID: 19862816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.